Is disease management right for oncology?

Population Health Management

Volumn 12, Issue 6, 2009, Pages 337-343

  Kash, Kathryn M ^a   Sharma, Smiriti ^a   Goldfarb, Neil I ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ANTIDEPRESSANT AGENT; CYTARABINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; TRASTUZUMAB;

ACNE; ANEMIA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER FATIGUE; CANCER INCIDENCE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CHRONIC DISEASE; CONCEPTUAL FRAMEWORK; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DEHYDRATION; DEPRESSION; DISEASE MANAGEMENT; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; HAND FOOT SYNDROME; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH INSURANCE; HEALTH PROGRAM; HOSPITAL INFECTION; HUMAN; LIFESTYLE MODIFICATION; ONCOLOGY; PATIENT ATTITUDE; PREVALENCE; PROSTATE CANCER; PSYCHOSOCIAL CARE; REVIEW; SKIN INFECTION; TERMINAL CARE;

DISEASE MANAGEMENT; HUMANS; INCIDENCE; MEDICAL ONCOLOGY; NEOPLASMS; PROGRAM DEVELOPMENT; PSYCHOLOGY; UNITED STATES;

EID: 73949151903     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2009.0029     Document Type: Review

References (32)

1. Rager RC. Employee disease management in US and global workplaces. Dis Manag Health Outcomes 2008;16:87-94.
2. Disease Management Association of America. Our mission. Available at: http://www.dmaa.org/about-our-mission.asp. Accessed August 2008.
3. Anderson GF. Medicare and chronic conditions. N Engl J Med 2005;353:305-309.
4. American Cancer Society. Cancer Facts and Figures 2009. Atlanta, GA: American Cancer Society; 2009.
5. Andriole GL, Crawford E, Grubb III RL, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:1310-1319.
6. Schroder FH, Hugissib J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-1328.
7. Regan M. Cancer and disease management: Indications for action. Dis Manage Health Outcomes 1999;6:203-211.
8. Romond E, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005;353:1673-1684.
9. Hortobagyi GN. Trastuzumab in the treatment of breast cancer. N Engl J Med 2005;353:1734-1736.
10. DuBard CA, Schmid D, Yow A, Rogers AB, Lawrence WW. Recommendation for and receipt of cancer screenings among Medicaid recipients 50 years and older. Arch Intern Med 2008;168:2014-2021.
11. Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 2008;100:630-641.
12. Cancer Disparities Research Partnership Program. Patient navigator. Available at: http://www3.cancer.gov/rrp/cdrp/ navigator.html. Accessed July 23, 2009.
13. National Cancer Institute. Fatigue (PDQA). Patient version. Available at: http://www.cancer.gov/cancertopics/pdq/ supportivecare/fatigue/Patient. Accessed July 23, 2009.
14. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Available at: http://www .nccn.org/professionals/physician-gls/f- guidelines.asp. Accessed June 12, 2009.
15. Lee FC. Is cancer meant to be managed? Managed Care Cancer 2001;3:28-33.
16. Shelke AR, Mustian KM, Morrow GR. The pathophysiology of treatment-related nausea and vomiting in cancer patients: Current models. Ind J Physiol Pharmacol 2004;48:256-268.
17. Costich T, Lee FC. Improving cancer care in a Kentucky managed care plan: A case study of cancer disease management. Dis Manag 2003;6:9-20.
18. Portenoy RK, Sibirceva BA, Smout R, et al. Opioid use and survival at the end of life: A survey of a hospice population. J Pain Symptom Manag 2006;32:532-540.
19. Wyatt AJ, Leonard GD, Sachs DL. Cutaneous reactions to chemotherapy and their management. Am J Clin Dermatol 2006;7:45-63.
20. Mays SR, Bogle MA, Bodey GP. Cutaneous fungal infections in the oncology patient: recognition and management. Am J Clin Dermatol 2006;7:31-43.
21. Adler NE, Page AEK, eds. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington DC: The National Academies Press; 2008.
22. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;32:57-71.
23. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association prevention committee of the council on cardiovascular nursing, council on clinical cardiology, council on epidemiology and prevention, and interdisciplinary council on quality of care and outcomes research: endorsed by the American Psychiatric Association. Circulation 2008;118:1768-1775.
24. Fetterolf DE, Terry R. Oncology disease management. Dis Manag 2007;10:30-36.
25. USA Today/Kaiser Family Foundation/Harvard School of Public Health. National survey of households affected by cancer. Available at: http://www.kff.org/Kaiserpolls/upload/ 7591.pdf. Accessed December 11, 2008.
26. Lee FC. Employer-based disease management programs in cancer. Dis Manag Health Outcomes 2004;12:9-17.
27. Sabin JE. Making insurance coverage for new technologies reasonable and accountable. JAMA 1998;279:703-704.
28. Teitelman DL, Lee FC. The Florida Blues' experience in improving cancer management. Oncol News Intl 2002;11:47-49.
29. Matheson D, Wilkins A, Psacharopoulos D. Realizing the promise of disease management. Available at: http://www .bcg.com/impact-expertise/publications/ files/Realizing-the- Promise-of-Disease-Management-Feb06.pdf. Accessed July 23, 2009.
30. Center on an Aging Society. Disease management programs. Improving health while reducing costs? Available at: http:// ihcrp.georgetown.edu/agingsociety/ pdfs/management.pdf. Accessed July 23, 2009.
31. Sipkoff M. Managing cancer treatment begins before diagnosis. Manag Care 2007;16:26-28, 30, 33-34.
32. The top six challenges in disease management. Available at: http://www.dmaa.org/pdf/TopSixChallengesinDM.pdf. Accessed July 23, 2009.